Shopping Cart
- Remove All
Your shopping cart is currently empty
Narsoplimab (OMS 721) is a selective whole-human immunoglobulin gamma-4 (IgG4) monoclonal antibody and a mannan-binding lectin-associated serine protease-2 (MASP-2) inhibitor that binds MASP-2 to prevent lectin pathway activation and inhibit the agglutinin pathway. It is used to study diseases associated with hematopoietic stem cell transplantation in adults.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $263 | In Stock | |
| 5 mg | $695 | In Stock | |
| 10 mg | $1,070 | In Stock | |
| 25 mg | $1,590 | In Stock | |
| 50 mg | $2,150 | In Stock |
| Description | Narsoplimab (OMS 721) is a selective whole-human immunoglobulin gamma-4 (IgG4) monoclonal antibody and a mannan-binding lectin-associated serine protease-2 (MASP-2) inhibitor that binds MASP-2 to prevent lectin pathway activation and inhibit the agglutinin pathway. It is used to study diseases associated with hematopoietic stem cell transplantation in adults. |
| In vitro | Narsoplimab (100 nM; 3 h; Vero E6 cells and Vero E6 cells with SARS-CoV-2) inhibits N protein-enhanced MASP-2 deposition[1]. |
| In vivo | Narsoplimab (10 mg/kg; i.v.; WT and Masp2-/- (KO) mice) reduced lymphocyte percentage (Lym%) and increased neutrophil percentage (Neu%)[1]. |
| Synonyms | OMS 721 |
| Molecular Weight | 143.1 kDa |
| Cas No. | 2108782-45-0 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.